StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) stock

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.06−0.44 (-12.57%)

Close on Nov 18, 2026Market cap $62.83KP/E –Yield –

Addex Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Addex Therapeutics's pe ratio was 0.0× on Feb 27, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 20260.0×−0.0
2025Dec 31, 20250.0×–

More Addex Therapeutics figures

See a number that looks wrong?